Cite
HARVARD Citation
Margoni, M. et al. (2019). Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis. Multiple sclerosis journal, experimental, translational and clinical. 5 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Margoni, M. et al. (2019). Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis. Multiple sclerosis journal, experimental, translational and clinical. 5 (3), p. . [Online].